CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in HRMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,431,431
+$3,902,600 QoQ
Shares Held
423,824
+3.0% QoQ
Ownership
0.728%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 328 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. HRMY ranks #81 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in HRMY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,431,431 | 423,824 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,528,831 | 411,597 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,639,876 | 417,955 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,578,411 | 456,401 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $13,835,775 | 437,841 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $15,468,929 | 466,072 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $16,242,483 | 472,028 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $14,857,680 | 371,442 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $11,304,940 | 374,708 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $12,542,667 | 373,516 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $10,309,094 | 319,167 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $9,533,153 | 290,911 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,733,278 | 248,175 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $7,310,628 | 223,909 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $12,435,629 | 225,692 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $11,325,218 | 255,706 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,476,751 | 235,324 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $12,668,022 | 260,391 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,386,969 | 267,049 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,893,671 | 232,029 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,337,452 | 47,377 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $454,861 | 13,767 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $467,997 | 12,946 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||